Answers are grounded in this paper and cite their sources.
What happens when your VP commits to shipping AI by Q1, but the feature doesn't exist yet? David Ohnstad recounts the October afternoon his team restructured around an unapproved anomaly detection system—and what actually matters when organizations bet on machine learning. Full article: https://davidohnstad.net/ai-product-roadmaps-building-teams-before-features/
No takes yet. Share an insight, caveat, or question.
David Ohnstad (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: